November 2014
In this Supplement
The Rise of Peripheral Drug Elution
How to incorporate drug-coated balloons and drug-eluting stents into your practice.
Issue
US Supplement
European
Supplement
Drug Elution, Data, and Decisions
What the data tell us about how to integrate drug-eluting technology into our daily practice.
By Gary Ansel, MD, and John A. Phillips, MD
An Overview of Superficial Femoral Artery Stenting
The history, data, and latest advancements in stenting of the SFA and popliteal arteries.
By John R. Laird, MD, and Ehrin J. Armstrong, MD
Zilver PTX for Simple and Challenging Lesions
How I integrate this versatile tool into my lower extremity practice.
By William A. Gray, MD
DCBs in the United States
The use of drug-coated balloons is creating a paradigm shift in the treatment of peripheral arterial disease by preventing restenosis and leaving nothing behind.
By George L. Adams, MD, MHS, and O Jesse Mendes, BA
DES and DEB Use in Europe
As devices develop and longer follow-up data become available, one thing is certain: It’s a drug-eluting world, all right.
By Konstantinos Katsanos, MSc, MD, PhD, EBIR
The Costs and Benefits of Medical Innovation
Looking beyond prices and assessing the true value of new technologies.
By Louis L. Nguyen, MD, MBA, MPH, and Rebecca E. Scully, MD
DES Versus Bypass for Femoropopliteal Disease
Should the current data on drug-eluting devices cause surgeons to reconsider when to use bypass?
By Marc Bosiers, MD, and Koen Deloose, MD
advertisement
Top 5 Articles From November 2014
Penetrating Aortic Ulcer and Intramural Hematoma
An update on how to differentiate and manage two potentially devastating diagnoses.
By Foeke Nauta, MD; Arnoud Kamman, MD; and Santi Trimarchi, MD, PhD
Coding Changes for 2015
Reviewing the changes and additions to endovascular coding effective January 1.
By Katharine L. Krol, MD, FSIR, FACR
Total Endovascular Repair of the Aortic Arch
An overview of branched arch devices on the horizon.
By Stéphan Haulon, MD, PhD; Jonathan Sobocinski, MD, PhD; Rafaelle Spear, MD; Jarin Kratzberg, PhD; Blayne Roeder, PhD; Richard Azzaoui, MD; and Blandine Maurel, MD, PhD
Minimally Invasive Sutureless Anastomosis of an AV Hemodialysis Graft
An overview of the InterGraft™ Vascular Anastomotic Connector System and a case report from the first-in-human study.
By Adrian Ebner, MD; John Ross, MD; and Alexander Yevzlin, MD
Arch Debranching Is Best
Without sufficient long-term data on the use of chimney or branched grafts, arch debranching is the preferred treatment modality.
By Stephen W. K. Cheng, MD
Top 5 from CIToday's Current Issue
Meeting the Challenge…
By Azeem Latib, MD
Massive Thromboembolism, PFO, and Acute Limb Ischemia
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
Radial Access for the Evaluation of Bypass Grafts
By Moderator: Mirvat Alasnag, MD, FACP, FSCAI, FRCP
Panelists: James Nolan, MBChB, FRCP, MD; Sunil Rao, MD; and Binita Shah, MD, MS, FACC, FSCAI
Compensation and Production Trends for Interventionalists
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
